Palisade Bio, Inc. (PALI) Financials
PALI Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 17.1 million | 3.0 million |
2023-06-30 | 18.3 million | 2.5 million |
2023-03-31 | 15.3 million | 1.5 million |
2022-12-31 | 15.8 million | 3.3 million |
PALI Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -2.7 million | 202000 |
2023-06-30 | -2.2 million | 144000 |
2023-03-31 | -3.5 million | 93000 |
2022-12-31 | -3.3 million | 86000 |
PALI Net Income
No data available :(
PALI Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 15.3 million | - | 239000 |
2023-06-30 | 16.4 million | - | 266000 |
2023-03-31 | 13.3 million | - | 291000 |
2022-12-31 | 12.4 million | - | 316000 |
PALI Shares Outstanding
PALI Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | - | 1.7 million | 1.7 million | - |
2023-06-30 | 4000 | 2.2 million | 1.4 million | - |
2023-03-31 | 4000 | 1.2 million | 1.5 million | - |
2022-12-31 | 10000 | 2.3 million | 1.5 million | - |
PALI Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | 1000 |
2023-06-30 | - | 27000 |
2023-03-31 | 250000 | 26000 |
2022-12-31 | - | 26000 |
PALI
Price: $7.74
52 week price:
Earnings Per Share: -27.00 USD
P/E Ratio: 1.38
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 369800
Market Capitalization: 3.5 million